88
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Evaluation of miRNA detection methods for the analytical characteristic necessary for clinical utilization

      review-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          miRNAs are promising biomarkers but methods for their measurement are not clear. We therefore examined three miRNA detection technologies and considered the analytical characteristics essential for clinical utilization. TaqMan assays, SplintR-qPCR and miREIA were compared for their absolute quantification bias, conformity and robustness. Absolute concentrations of miR-142-5p, miR-23a-3p and miR-93-5p were measured with all three methods using 30 samples. Robustness was evaluated by measurement of miR-21-5p in five uniform experiments. Correlations were miRNA-specific, but we observed a different absolute concentration range in RT-qPCR (fmol/μl) and methods evading the RT process (amol/μl). Consistently, RT-less methods reported better robustness (CV 8–19%) than RT-qPCR (CV 39–50%). The calibration curve in TaqMan Advanced assay was influenced by dilution media. Methods avoiding RT seem to be a promising future alternative for miRNA measurement.

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          MicroRNA as Biomarkers and Diagnostics.

          MicroRNAs (miRNAs) are a group of small non-coding RNAs that are involved in regulating a range of developmental and physiological processes; their dysregulation has been associated with development of diseases including cancer. Circulating miRNAs and exosomal miRNAs have also been proposed as being useful in diagnostics as biomarkers for diseases and different types of cancer. In this review, miRNAs are discussed as biomarkers for cancer and other diseases, including viral infections, nervous system disorders, cardiovascular disorders, and diabetes. We summarize some of the clinical evidence for the use of miRNAs as biomarkers in diagnostics and provide some general perspectives on their use in clinical situations. The analytical challenges in using miRNAs in cancer and disease diagnostics are evaluated and discussed. Validation of specific miRNA signatures as biomarkers is a critical milestone in diagnostics.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Regulation of microRNA function in somatic stem cell proliferation and differentiation.

            microRNAs (miRNAs) are important modulators of development. Owing to their ability to simultaneously silence hundreds of target genes, they have key roles in large-scale transcriptomic changes that occur during cell fate transitions. In somatic stem and progenitor cells--such as those involved in myogenesis, haematopoiesis, skin and neural development--miRNA function is carefully regulated to promote and stabilize cell fate choice. miRNAs are integrated within networks that form both positive and negative feedback loops. Their function is regulated at multiple levels, including transcription, biogenesis, stability, availability and/or number of target sites, as well as their cooperation with other miRNAs and RNA-binding proteins. Together, these regulatory mechanisms result in a refined molecular response that enables proper cellular differentiation and function.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              microRNA regulation of inflammatory responses.

              The mammalian inflammatory response is a rapid and complex physiological reaction to noxious stimuli including microbial pathogens. Although inflammation plays a valuable role in combating infection, its dysregulation often occurs in people and can cause a variety of pathologies, ranging from chronic inflammation, to autoimmunity, to cancer. In recent years, our understanding of both the cellular and molecular networks that regulate inflammation has improved dramatically. Although much of the focus has been on the study of protein regulators of inflammation, recent evidence also points to a critical role for a specific class of noncoding RNAs, called microRNAs (miRNAs), in managing certain features of the inflammatory process. In this review, we discuss recent advances in our understanding of miRNAs and their connection to inflammatory responses. Additionally, we consider the link between perturbations in miRNA levels and the onset of human inflammatory diseases.
                Bookmark

                Author and article information

                Journal
                BTN
                BioTechniques
                BioTechniques
                BioTechniques
                Future Science Ltd (London, UK )
                0736-6205
                1940-9818
                24 May 2019
                June 2019
                : 66
                : 6
                : 277-284
                Affiliations
                1Central European Institute of Technology, Masaryk University, Brno, Czech Republic
                2BioVendor – Laboratorní medicína a.s., Brno, Czech Republic
                3Faculty of Medicine, Masaryk University, Brno, Czech Republic
                4International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic
                5Department of Neurology, St Anne's University Hospital, Brno, Czech Republic
                6Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care, Brno, Czech Republic
                7Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
                Author notes
                [* ]Author for correspondence: krepelkova@ 123456biovendor.com
                [‡]

                These authors contributed equally

                Article
                10.2144/btn-2019-0021
                31124705
                e1ec22a0-e9f6-46ff-b7bb-1910c6a5bd8c
                © 2019 BioVendor – Laboratorni medicina a.s.

                This work is licensed under the Creative Commons Attribution 4.0 License

                History
                : 20 February 2019
                : 02 April 2019
                : 24 May 2019
                Page count
                Pages: 8
                Categories
                Report

                General life sciences,Cell biology,Molecular biology,Biotechnology,Genetics,Life sciences
                SplintR-qPCR,miRNA biomarkers,RT-qPCR,miREIA,miRNA enzyme immunoassay

                Comments

                Comment on this article